Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Irritable Bowel Syndrome, February 2019

Free Subscription


Abstracts

Retrieve all available abstracts of the following 65 articles:
HTML format


 

Single Articles

  1. SIRI S, Maier F, Chen L, Santos S, et al
    Differential biomechanical properties of mouse distal colon and rectum innervated by the splanchnic and pelvic afferents.
    Am J Physiol Gastrointest Liver Physiol. 2019.
    Abstract    

    Abstract available

  2. HASAN SS, Pearson JS, Morris J, Whorwell PJ, et al
    SKYPE HYPNOTHERAPY FOR IRRITABLE BOWEL SYNDROME: Effectiveness and Comparison with Face-to-Face Treatment.
    Int J Clin Exp Hypn. 2019;67:69-80.
    Abstract    

    Abstract available

  3. FADEEVA NA, Korneeva IA, Knyazev OV, Parfenov AI, et al
    Biomarkers of inflammatory bowel disease activity.
    Ter Arkh. 2018;90:107-111.
    Abstract    

    Abstract available

  4. MAEV IV, Kazulin AN, Andreev DN
    The cardiovascular system in patients with functional and inflammatory bowel diseases.
    Ter Arkh. 2018;90:59-64.
    Abstract    

    Abstract available

  5. TUTEJA AK, Talley NJ, Stoddard GJ, Samore MH, et al
    Risk factors for upper and lower functional gastrointestinal disorders in Persian Gulf War Veterans during and post-deployment.
    Neurogastroenterol Motil. 2019 Jan 29:e13533. doi: 10.1111/nmo.13533.
    Abstract    

    Abstract available

  6. FANI M, Mostamand J, Fani M, Chitsaz N, et al
    The effect of aerobic exercises among women with mild and moderate irritable bowel syndrome: A pilot study.
    J Bodyw Mov Ther. 2019;23:161-165.
    Abstract    

    Abstract available

  7. ZHANG L, Liu YX, Wang Z, Wang XQ, et al
    Clinical characteristic and fecal microbiota responses to probiotic or antidepressant in patients with diarrhea-predominant irritable bowel syndrome with depression comorbidity: a pilot study.
    Chin Med J (Engl). 2019;132:346-351.
    Abstract    



  8. NIKKHAH BODAGH M, Maleki I, Hekmatdoost A
    Ginger in gastrointestinal disorders: A systematic review of clinical trials.
    Food Sci Nutr. 2018;7:96-108.
    Abstract    

    Abstract available

  9. SAMPAIO F, Bonnert M, Olen O, Hedman E, et al
    Cost-effectiveness of internet-delivered cognitive-behavioural therapy for adolescents with irritable bowel syndrome.
    BMJ Open. 2019;9:e023881.
    Abstract    

    Abstract available

  10. FIFI AC, Saps M
    Diet and Functional Gastrointestinal Disorders in Children. Is the Focus on Food Exaggerated?
    Nutrients. 2019;11.
    Abstract    

    Abstract available

  11. ZHAO HD, Zhao SM, Chen YX, Li CT, et al
    Formula Derivation for the Probability Distribution of IBS Score in Unrelated Individual Pairs.
    Fa Yi Xue Za Zhi. 2018;34:370-374.
    Abstract    

    Abstract available

  12. RENZI C, Lyratzopoulos G, Hamilton W, Rachet B, et al
    Opportunities for reducing emergency diagnoses of colon cancer in women and men: A data-linkage study on pre-diagnostic symptomatic presentations and benign diagnoses.
    Eur J Cancer Care (Engl). 2019 Feb 8:e13000. doi: 10.1111/ecc.13000.
    Abstract    

    Abstract available

  13. WEIBERT E, Stengel A
    [The Role of Psychotherapy in the Treatment of Irritable Bowel Syndrome].
    Psychother Psychosom Med Psychol. 2019 Feb 7. doi: 10.1055/a-0829-6990.
    Abstract    

    Abstract available

  14. SCHAFER SK, Weidner KJ, Becker N, Lass-Hennemann J, et al
    [Sensitivity and Specificity of the Reizdarm-Fragebogen].
    Psychother Psychosom Med Psychol. 2019 Feb 7. doi: 10.1055/a-0834-6207.
    Abstract    

    Abstract available

  15. WANG XS, Yue J, Hu LN, Tian Z, et al
    Effects of CPEB1 in the anterior cingulate cortex on visceral pain in mice.
    Brain Res. 2019 Feb 4. pii: S0006-8993(19)30069.
    Abstract    

    Abstract available

  16. HASTINGS J, Forster JE, Witzeman K
    Joint Hypermobility Among Female Patients Presenting with Chronic Myofascial Pelvic Pain.
    PM R. 2019 Feb 6. doi: 10.1002/pmrj.12131.
    Abstract    

    Abstract available

  17. JIN Q, Duan S, Li G, Sun L, et al
    Sex-related differences in resting-state brain activity and connectivity in the orbital frontal cortex and insula in patients with functional constipation.
    Neurogastroenterol Motil. 2019 Feb 6:e13566. doi: 10.1111/nmo.13566.
    Abstract    

    Abstract available

  18. SHARMA A, Adarsh MB, Dogra S, Vaiphei K, et al
    Evaluation of subclinical gut inflammation using fecal calprotectin levels and colonic mucosal biopsy in psoriasis and psoriatic arthritis patients.
    Br J Dermatol. 2019 Feb 6. doi: 10.1111/bjd.17745.
    Abstract    

    Abstract available

  19. MCCLELLAN N, Ahlawat R, Destrez A, Grimm P, et al
    Dietary-induced modulation of the hindgut microbiota is related to behavioral responses during stressful events in horses.
    Physiol Behav. 2019 Feb 3. pii: S0031-9384(18)30987.
    Abstract    

    Abstract available

  20. VELASCO-BENITEZ CA, Ramirez-Hernandez CR, Moreno-Gomez JE, Jativa-Marino E, et al
    [Overlapping of functional gastrointestinal disorders in latinamerican schoolchildren and adolescents].
    Rev Chil Pediatr. 2018;89:726-731.
    Abstract    

    Abstract available

  21. ZHOU Y, Han S, He Y
    Clinical Effects and Safety of Tongxieyaofang on Diarrhea Predominant Irritable Bowel Syndrome: A Meta-Analysis of Randomized Trails.
    Evid Based Complement Alternat Med. 2019;2019:4893876.
    Abstract    

    Abstract available

  22. ANDERSON PO
    A Guide to Treating Irritable Bowel Syndrome While Breastfeeding.
    Breastfeed Med. 2019 Feb 5. doi: 10.1089/bfm.2019.0005.
    Abstract    



  23. GRAZIANI C, Talocco C, De Sire R, Petito V, et al
    Intestinal permeability in physiological and pathological conditions: major determinants and assessment modalities.
    Eur Rev Med Pharmacol Sci. 2019;23:795-810.
    Abstract    

    Abstract available

  24. WU IXY, Wong CHL, Ho RST, Cheung WKW, et al
    Acupuncture and related therapies for treating irritable bowel syndrome: overview of systematic reviews and network meta-analysis.
    Therap Adv Gastroenterol. 2019;12:1756284818820438.
    Abstract    

    Abstract available

  25. PICARD E, Carvalho FA, Agosti F, Bourinet E, et al
    Cav3.2 calcium channel inhibition: a new target for colonic hypersensitivity associated with low-grade inflammation.
    Br J Pharmacol. 2019 Feb 4. doi: 10.1111/bph.14608.
    Abstract    

    Abstract available

  26. EKINCI RMK, Balci S, Akay E, Tumgor G, et al
    Frequency of functional gastrointestinal disorders in children with familial Mediterranean fever.
    Clin Rheumatol. 2019 Jan 31. pii: 10.1007/s10067-019-04452.
    Abstract    

    Abstract available

  27. LEI WY, Chen CL
    Reply to: "The type of dyspepsia is important in the context of patients with irritable bowel syndrome and gastroesophageal reflux disease".
    J Formos Med Assoc. 2019 Jan 28. pii: S0929-6646(19)30010.
    Abstract    



  28. HAGIWARA SI, Hasdemir B, Heyman MB, Chang L, et al
    Plasma Corticotropin-Releasing Factor Receptors and B7-2(+) Extracellular Vesicles in Blood Correlate with Irritable Bowel Syndrome Disease Severity.
    Cells. 2019;8.
    Abstract    

    Abstract available

  29. RODINO-JANEIRO BK, Pardo-Camacho C, Santos J, Martinez C, et al
    Mucosal RNA and Protein Expression as the next frontier in IBS: abnormal function despite morphologically intact small intestinal Mucosa.
    Am J Physiol Gastrointest Liver Physiol. 2019.
    Abstract    

    Abstract available

  30. LITLESKARE S, Rortveit G, Eide GE, Emberland KE, et al
    Quality of life and its association with irritable bowel syndrome and fatigue ten years after giardiasis.
    Neurogastroenterol Motil. 2019 Feb 14:e13559. doi: 10.1111/nmo.13559.
    Abstract    

    Abstract available

  31. SUN Q, Jia Q, Song L, Duan L, et al
    Alterations in fecal short-chain fatty acids in patients with irritable bowel syndrome: A systematic review and meta-analysis.
    Medicine (Baltimore). 2019;98:e14513.
    Abstract    

    Abstract available

  32. REJ A, Sanders DS
    The overlap of irritable bowel syndrome and noncoeliac gluten sensitivity.
    Curr Opin Gastroenterol. 2019 Feb 12. doi: 10.1097/MOG.0000000000000517.
    Abstract    

    Abstract available

  33. AHMED M, Habis S, Saeed R, Mahmoud A, et al
    Submucosal Lipomas Causing Intussusception and Small Bowel Obstruction: A Case Report.
    Cureus. 2018;10:e3692.
    Abstract    

    Abstract available

  34. REDDEL S, Putignani L, Del Chierico F
    The Impact of Low-FODMAPs, Gluten-Free, and Ketogenic Diets on Gut Microbiota Modulation in Pathological Conditions.
    Nutrients. 2019;11.
    Abstract    

    Abstract available

  35. SWENSON CW, Schimpf MO, Menees SB, Haefner HK, et al
    Comparison of Serum Vitamin D Levels in Relation to Bowel and Bladder Symptoms in Women with Vulvar Diseases.
    Int J Vitam Nutr Res. 2019 Feb 12:1-7. doi: 10.1024/0300-9831/a000527.
    Abstract    

    Abstract available

  36. GAJULA P, Quigley EM
    Overlapping irritable bowel syndrome and inflammatory bowel disease.
    Minerva Gastroenterol Dietol. 2019 Feb 11. pii: S1121-421X.19.02559.
    Abstract    

    Abstract available

  37. ADRIANI A, Saracco GM, Pellicano R
    Irritable bowel syndrome: a picture of the US real world.
    Minerva Gastroenterol Dietol. 2019 Feb 11. pii: S1121-421X.19.02558.
    Abstract    



  38. LI Y, Yang T, Yao Q, Li S, et al
    Metformin prevents colonic barrier dysfunction by inhibiting mast cell activation in maternal separation-induced IBS-like rats.
    Neurogastroenterol Motil. 2019 Feb 10:e13556. doi: 10.1111/nmo.13556.
    Abstract    

    Abstract available

  39. FASSOV J, Lundby L, Laurberg S, Krogh K, et al
    Sacral nerve modulation for irritable bowel syndrome: A randomized, double-blinded, placebo-controlled crossover study.
    Neurogastroenterol Motil. 2019 Feb 21:e13570. doi: 10.1111/nmo.13570.
    Abstract    

    Abstract available

  40. LIN M, Chen L, Xiao Y, Yu B, et al
    Activation of cannabinoid 2 receptor relieves colonic hypermotility in a rat model of irritable bowel syndrome.
    Neurogastroenterol Motil. 2019 Feb 21:e13555. doi: 10.1111/nmo.13555.
    Abstract    

    Abstract available

  41. NAKAJIMA A, Taniguchi S, Kurosu S, Gillberg PG, et al
    Efficacy, long-term safety, and impact on quality of life of elobixibat in more severe constipation: Post hoc analyses of two phase 3 trials in Japan.
    Neurogastroenterol Motil. 2019 Feb 21:e13571. doi: 10.1111/nmo.13571.
    Abstract    

    Abstract available

  42. MA C, Battat R, Parker CE, Khanna R, et al
    Update on C-reactive protein and fecal calprotectin: are they accurate measures of disease activity in Crohn's disease?
    Expert Rev Gastroenterol Hepatol. 2019.
    Abstract    

    Abstract available

  43. BARBALHO SM, Goulart RA, Araujo AC, Guiguer EL, et al
    Irritable bowel syndrome: a review of the general aspects and the potential role of vitamin D.
    Expert Rev Gastroenterol Hepatol. 2019.
    Abstract    

    Abstract available

  44. NEE JW, Johnston JM, Shea EP, Walls CE, et al
    Safety and tolerability of linaclotide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: pooled Phase 3 analysis.
    Expert Rev Gastroenterol Hepatol. 2019.
    Abstract    

    Abstract available

  45. BASSOTTI G, Usai Satta P, Bellini M
    Prucalopride for the treatment of constipation: a view from 2015 and beyond.
    Expert Rev Gastroenterol Hepatol. 2019;13:257-262.
    Abstract    

    Abstract available

  46. SOARES RLS
    IRRITABLE BOWEL SYNDROME, FOOD INTOLERANCE AND NON- CELIAC GLUTEN SENSITIVITY. A NEW CLINICAL CHALLENGE.
    Arq Gastroenterol. 2018;55:417-422.
    Abstract    

    Abstract available

  47. RUEMMELE FM
    Non-Celiac Gluten Sensitivity: A Challenging Diagnosis in Children with Abdominal Pain.
    Ann Nutr Metab. 2018;73 Suppl 4:39-46.
    Abstract    

    Abstract available

  48. CHANDAN JS, Thomas T, Raza K, Bandyopadhyay S, et al
    Association between child maltreatment and central sensitivity syndromes: a systematic review protocol.
    BMJ Open. 2019;9:e025436.
    Abstract    

    Abstract available

  49. LARUSSA T, Rossi M, Suraci E, Marasco R, et al
    Use of Complementary and Alternative Medicine by Patients with Irritable Bowel Syndrome According to the Roma IV Criteria: A Single-Center Italian Survey.
    Medicina (Kaunas). 2019;55.
    Abstract    

    Abstract available

  50. VAKHSHUURY M, Khoshdel A
    The Relation between Dietary Patterns and Functional Gastrointestinal Disorders among Iranian Military Men.
    Adv Biomed Res. 2019;8:2.
    Abstract    

    Abstract available

  51. ZARGAR A, Gooraji SA, Keshavarzi B, Haji Aghamohammadi AA, et al
    Effect of Irritable Bowel Syndrome on Sleep Quality and Quality of Life of Inflammatory Bowel Disease in Clinical Remission.
    Int J Prev Med. 2019;10:10.
    Abstract    

    Abstract available

  52. HOSSEINI OSKOUIE F, Vahedi H, Shahrbaf MA, Sadeghi A, et al
    Dietary fiber and risk of irritable bowel syndrome: a case-control study.
    Gastroenterol Hepatol Bed Bench. 2018;11.
    Abstract    

    Abstract available

  53. SHARMA A, Herekar AA, Bhagatwala J, Rao SS, et al
    Profile of plecanatide in the treatment of chronic idiopathic constipation: design, development, and place in therapy.
    Clin Exp Gastroenterol. 2019;12:31-36.
    Abstract    

    Abstract available

  54. KOUTOURATSAS T, Kalli T, Karamanolis G, Gazouli M, et al
    Contribution of ghrelin to functional gastrointestinal disorders' pathogenesis.
    World J Gastroenterol. 2019;25:539-551.
    Abstract    

    Abstract available

  55. HO SW, Lin CP, Ku MS
    The impact of allergic rhinitis on gastrointestinal disorders among young adults.
    J Eval Clin Pract. 2019 Feb 17. doi: 10.1111/jep.13108.
    Abstract    

    Abstract available

  56. KOLOSKI N, Jones M, Walker MM, Veysey M, et al
    Population based study: atopy and autoimmune diseases are associated with functional dyspepsia and irritable bowel syndrome, independent of psychological distress.
    Aliment Pharmacol Ther. 2019 Jan 27. doi: 10.1111/apt.15120.
    Abstract    

    Abstract available

  57. KESHTELI AH, Madsen KL, Mandal R, Boeckxstaens GE, et al
    Comparison of the metabolomic profiles of irritable bowel syndrome patients with ulcerative colitis patients and healthy controls: new insights into pathophysiology and potential biomarkers.
    Aliment Pharmacol Ther. 2019 Jan 31. doi: 10.1111/apt.15141.
    Abstract    

    Abstract available

  58. VIJAYVARGIYA P, Camilleri M, Burton D, Busciglio I, et al
    Bile and fat excretion are biomarkers of clinically significant diarrhoea and constipation in irritable bowel syndrome.
    Aliment Pharmacol Ther. 2019 Feb 10. doi: 10.1111/apt.15106.
    Abstract    

    Abstract available

  59. LUSTBADER I
    Continuing Medical Education Questions: February 2019.
    Am J Gastroenterol. 2019;114:200.
    Abstract    

    Abstract available

  60. PERERA LP, Radigan M, Guilday C, Banerjee I, et al
    Presence of Irritable Bowel Syndrome Symptoms in Quiescent Inflammatory Bowel Disease Is Associated with High Rate of Anxiety and Depression.
    Dig Dis Sci. 2019 Feb 6. pii: 10.1007/s10620-019-05488.
    Abstract    

    Abstract available

  61. HARRIS LA
    Rifaximin for Irritable Bowel Syndrome (IBS) in Gulf War Veterans: Losing the Battle but Winning the War?
    Dig Dis Sci. 2019 Feb 6. pii: 10.1007/s10620-019-05505.
    Abstract    



  62. MARCUZZI A, Chakiath RJ, Siddall PJ, Kellow JE, et al
    Conditioned Pain Modulation (CPM) is Reduced in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of CPM and the Role of Psychological Factors.
    J Clin Gastroenterol. 2019 Feb 5. doi: 10.1097/MCG.0000000000001181.
    Abstract    

    Abstract available

  63. CAPURSO L
    Thirty Years of Lactobacillus rhamnosus GG: A Review.
    J Clin Gastroenterol. 2019;53 Suppl 1:S1-S41.
    Abstract    

    Abstract available

  64. LJOTSSON B
    What are the mechanisms of psychological treatments for irritable bowel syndrome?
    J Psychosom Res. 2019;118:9-11.
    Abstract    



  65. BISTOLETTI M, Caputi V, Baranzini N, Marchesi N, et al
    Antibiotic treatment-induced dysbiosis differently affects BDNF and TrkB expression in the brain and in the gut of juvenile mice.
    PLoS One. 2019;14:e0212856.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;